U.S. Healthcare Solutions was Cencora’s largest segment in fiscal 2025, bringing in $285.29B of $309.68B (92%).
| Segment | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. Healthcare Solutions | $207.28B | $229.72B | $259.97B | $285.29B | |||||||||||
| Pharmaceutical Distribution Services | — | — | — | — | |||||||||||
| Pharmaceutical Distribution | — | — | — | — | |||||||||||
| Revenues | — | — | — | — | |||||||||||
| International Healthcare Solutions | $21.89B | $22.35B | $23.06B | $24.39B | |||||||||||
| Mwi Animal Health | — | — | — | — | |||||||||||
| Other | — | — | — | — | |||||||||||
| Other Segments | — | — | — | — | |||||||||||
| Global Commercialization Services | — | — | — | — | |||||||||||
| Total | $229.17B | $252.07B | $283.04B | $309.68B |
Cencora brought in $309.68B from its two segments in fiscal 2025, the year ended September 30, 2025. That was up 9.4% from $283.04B in fiscal 2024. U.S. Healthcare Solutions was the largest at $285.29B (92.1%), ahead of International Healthcare Solutions at $24.39B (7.9%).
Compared with fiscal 2024, U.S. Healthcare Solutions grew 9.7% to $285.29B and International Healthcare Solutions grew 5.8% to $24.39B. From fiscal 2022 to 2025, combined revenue from these segments grew from $229.17B to $309.68B, a compound annual growth rate of 10.6%. U.S. Healthcare Solutions' share of the total rose from 90.4% to 92.1%.
Human Health was Cencora’s largest segment in fiscal 2025, bringing in $285.29B of $321.35B (89%).
| Subsegments | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Human Health | $207.28B | $229.72B | $259.97B | $285.29B | |
| Alliance Healthcare | $21.89B | $22.35B | $23.06B | $24.39B | |
| Animal Health | $4.82B | $5.04B | $5.37B | $5.69B | |
| Other Healthcare Solutions | $4.60B | $5.07B | $5.57B | $5.97B | |
| Total | $238.59B | $262.18B | $293.97B | $321.35B |
Cencora brought in $321.35B from its four segments in fiscal 2025, the year ended September 30, 2025. That was up 9.3% from $293.97B in fiscal 2024. Human Health was the largest at $285.29B (88.8%), ahead of Alliance Healthcare at $24.39B (7.6%) and Other Healthcare Solutions at $5.97B (1.9%). The remaining segment, Animal Health, brought in $5.69B.
Compared with fiscal 2024, Human Health grew 9.7% to $285.29B and Alliance Healthcare grew 5.8% to $24.39B. From fiscal 2022 to 2025, combined revenue from these segments grew from $238.59B to $321.35B, a compound annual growth rate of 10.4%. Human Health's share of the total rose from 86.9% to 88.8%.
Cencora (COR) reports its revenue by segment and by subsegments. In fiscal 2025, U.S. Healthcare Solutions was its largest segment, bringing in $285.29B (92.1% of the total), followed by International Healthcare Solutions at $24.39B (7.9%).
U.S. Healthcare Solutions was Cencora's largest segment in fiscal 2025, bringing in $285.29B, or 92.1% of the $309.68B total across its two segments.
U.S. Healthcare Solutions grew faster than International Healthcare Solutions in fiscal 2025, up 9.7% from $259.97B to $285.29B. International Healthcare Solutions grew 5.8% to $24.39B.
Every figure comes from Cencora's annual financial filings, as reported. Each line keeps the name Cencora gives it, and years follow its fiscal calendar.
Cencora's revenue by segment goes back to fiscal 2010, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.